Multicenter retrospective evaluation of treatment for high-risk Acute Promyelocytic Leukemia (APL)
Total number of HERO sites: 7
Status: Abstract presented at 2023 American Society of Hematology Annual Meeting
EVALUATION OF LOW-INTENSITY TREATMENT STRATEGIES AND OUTCOMES IN PATIENTS WITH ACCELERATED PHASE AND BLAST PHASE MYELOPROLIFERATIVE NEOPLASMS: A HEMATOLOGY RESEARCH OUTCOMES (HERO) CONSORTIUM STUDY
Total number of HERO sites: 9
Status: Abstract presented at the 2025 American Society of Hematology Annual Meeting
Publication: In progress
New!